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ABSTRACT 
Primary cardiac lymphomas (PCL) are extremely rare. Clinical manifestations may be variable and are attributed 
to location. Here, we report on a case of PCL presenting with atrioventricular (AV) block. A 55 year-old male 
had experienced chest discomfort with unexplained dyspnea and night sweating. His initial electrocardiogram 
(ECG) revealed a first degree AV block. Along with worsening chest discomfort and dyspnea, his ECG changed 
to show second degree AV block (Mobitz type I). Computed tomography (CT) scan showed a cardiac mass (about 
7 cm) and biopsy was performed. Pathologic finding confirmed diffuse large B-cell lymphoma. The patient was 
treated with multi-drug combination chemotherapy (R-CHOP: Rituximab, cyclophoshamide, anthracycline, vin-
cristine, and prednisone). After treatment, ECG changed to show normal sinus rhythm with complete remission 
on follow-up CT scan. (Korean Circ J 2010;40:94-98) 
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Introduction 
 
Primary cardiac lymphomas (PCL) are extremely rare, 
accounting for only 2% of primary cardiac tumors and 
0.5% of extranodal lymphomas. Clinical manifestations 
may vary and are attributed to location, and presence of 
congestive heart failure, pericardial effusion, or arrhy-
thmia. Here we report a case of PCL presenting with 
atrioventricular (AV) block. 
 
Case 
 
A 55 year-old man with no previous history of car-
diac disease and well controlled hypertension visited the 
outpatient cardiology department. The patient had ex-
perienced discomfort in his chest with unexplained dy-
spnea for 4 days. He complained of severe night sweats 
as well, but could not recall the exact time when symp-
toms started. He had smoked a pack a day for the past 
30 years. Findings from physical examination were not 
specific; no palpable lymph nodes, palpable liver, or sp-
leen were observed. Initial lab results showed no re-
markable findings, with the exception of mild pro Brain 
Natriuretic Peptide (BNP) elevation to 568.4 pg/mL. The 
patient’s initial electrocardiogram (ECG) revealed first 
degree AV block (Fig. 1). Chest radiography was close 
to normal. A well delineated lesion adjacent to the as-
cending aorta was observed in transthoracic echocar-
diography (TTE). Consequently, thoracic aorta CT was 
performed; a multi-lobulating, low density mass (about 
7 cm) with an irregular shape was observed in the right 
atrium (RA) and extended to the periaortic space of 
the ascending aorta and left atrium (Fig. 2). The lesion 
adjacent to the ascending aorta in TTE was revealed as 
a cardiac mass by CT scan. The patient was referred to 
the hemato-oncology department, and scheduled to un-
dergo biopsy of the cardiac mass within a few days at 
the department of chest surgery. 
However, before the scheduled appointment for bio-
psy, the patient was rushed to the emergency room for 
worsening chest discomfort, dyspnea, and palpitation. 
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Mobitz type I in second degree AV block was detected 
on ECG while the patient was complaining of symp- 
toms (Fig. 3A). The patient underwent 24 hour holter 
monitoring. Although there was no direct clinical cor-
relation with AV block, 2：1 AV block was found in 
the readings (Fig. 3B). Mediastinotomy via right para-
sternal incision was performed, followed by tumor bio-
psy. Surgical findings showed that the mass was not en-
gaging with the pericardium and that it surrounded 
the RA and aorta, as in the CT reading. Partial invasion 
of the mass into the myocardium was observed, but in 
general, the mass was not engaged. H&E staining reve-
aled large lymphocytes with high mitotic activity show-
ing diffuse infiltration. In immunochemical staining, 
CD 20 (the B cell marker) showed a positive result, while 
CD 3 (the T cell marker) showed a negative result (Fig. 
4). Pathologic finding confirmed diffuse large B-cell 
lymphoma. The lymphoma staging work-up included 
abdominal pelvic CT scan, bone marrow biopsy, and oto-
laryngologic exam. Beyond the cardiac lesion observed 
during the extensive evaluation described above, there 
was no evidence of lymphoma involvement. The patient 
received a final diagnosis of primary cardiac diffuse large 
B-cell lymphoma. The patient was treated with 6 cycles 
of combination chemotherapy (R-CHOP: Rituximab, 
cyclophoshamide, anthracycline, vincristine, and pred-
nisone). After 3 cycles of treatment, his ECG was con-
verted to normal sinus rhythm (Fig. 5), and follow-up CT 
scan showed that the cardiac mass had almost comple-
tely disappeared (Fig. 6).  
After 6 cycles of treatment, a positron emission to-
mography (PET) CT scan was performed from cerebel-
Fig. 1. ECG showing first degree AV block. AV: atrioventricular, ECG: electrocardiogram.
A  B
Fig. 2. Thoracic aorta CT demonstrating a multi-lobulating, low density mass (about 7 cm) with an irregular shape in the right atrium,
extending to the periaortic space of the ascending aorta and left atrium (arrows). A: coronal view. B: sagittal view. LV: left ventricle, LA:
left atrium, RV: right ventricle.  
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lum to pelvis. PET-CT scan inclusive of the heart and 
other sites found no evidence of hypermetabolic lesion, 
an indication of malignancy (Fig. 7). The patient went 
into a state of complete remission and was followed up 
at our outpatient hemato-oncology department.   
 
Disscussion 
 
PCL is extremely rare, accounting for only 2% of 
primary cardiac tumors
1) and 0.5% of extranodal lym-
phomas.
2) About 100 cases have been described in the 
literature, mostly as case reports or small case series.
3) 
Only 6 cases have been reported in Korea.
4-8) However, 
secondary cardiac involvement of malignant lymphoma 
is relatively common and was found in up to 25% of 
autopsy cases.
9) 
In 1977, McAllister and Fenoglio
2) defined PCL as 
an extranodal lymphoma involving only the heart and/ 
or pericardium. Cairns et al.
10) suggested that PCL could 
also present elsewhere as small secondary lesions, with 
the vast bulk of the tumor arising in the heart. Cur-
rently, the accepted definition of PCL is a lymphoma 
presenting as cardiac disease, particularly if the bulk of 
the tumor is intrapericardial.
11) 
Pathognomonic clinical presentation has not been 
described, and is generally related to sites of involve-
ment in the heart. In the majority of cases, PCL was 
reported as arising in the right chambers of the heart; 
the atria are involved in most patients studied. Right-
sided involvement predominates in primary cardiac 
A 
B 
Fig. 3. ECG showing second degree AV block. A: Mobitz type I. B: 2 : 1 AV block. AV: atrioventricular, ECG: electrocardiogram.
Fig. 4. Histologic findings. A: in H&E staining, large lymphocytes with high mitotic activity showed diffuse infiltration. In immunochemical
staining. B: CD 20, the B cell marker, showed a positive result. C: CD 3, the T cell marker, showed a negative result. 
A  B  C 
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lymphoma, in contrast to left-sided predominance in 
atrial myxoma, which is the major primary benign car-
diac tumor. 
The most common presentation is arrhythmia, fol-
lowed by pericardial effusion, with tamponade, dyspnea, 
and cardiac failure. Unusual presentations, including 
superior vena cava syndrome, embolic stroke, or symp-
toms suggestive of gastrointestinal disease may occur. 
The ECG was found not to be useful, and chest ra-
diography tended to reveal only nonspecific findings, 
such as a cardiomegaly or pleural effusion. TTE identi-
fied an intracardiac mass in 60% of cases, and trans-
oesphageal echocardiography (TEE) identified intra-
cardiac masses in 97% of cases.
12) Echocardiography re-
presents the most sensitive noninvasive technique for 
identification of PCL, particularly the transesophageal 
approach. CT and cardiac magnetic resonance (MR) are 
the techniques most commonly utilized. Contrast en-
hanced CT and MR offer the advantages of better con-
trast resolution and simultaneous visualization of the 
great vessels, heart, pericardium, mediastinum, and lung. 
Furthermore, CT and MR may present information 
useful for differential diagnosis of tumors, depending 
on their CT density and/or MR signal intensity char-
acteristics, particularly in cardiac lipoma, osteochondro-
sarcoma, and pericardial cysts.
13) Usefulness of nuclear 
medicine techniques, such as PET CT, has also been 
demonstrated in identification of metastatic foci and 
in follow-up. 
Definitive diagnosis of PCL is made on the basis of 
Fig. 5. ECG showing normal PR interval after 3 cycles of chemotherapy. ECG: electrocardiogram. 
Fig. 6. Thoracic aorta CT revealing disappearance of the cardiac mass after 3 cycles of chemotherapy. A: coronal view. B: sagittal view.
LV: left ventricle, LA: left atrium, RV: right ventricle, RA: right atrium. 
A  B 
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histology/cytology and is mandatory for appropriate 
therapy. If pericardial or pleural effusions are present, 
cytology is diagnostic in only two-thirds of cases.
14) When 
cytology is not available, diagnosis of PCL is deter-
mined primarily by biopsy of cardiac tissue during ex-
plorative thoracotomy. To avoid thoracotomy, less in-
vasive procedures, including mediastinoscopy, TEE-guid-
ed biopsy, thoracoscopic pericardial window, and en-
domyocardial transvenous biopsy are performed.   
According to the World Health Organization classifi-
cation, diffuse B-cell lymphoma, mainly of the large cell 
subtype, was observed in most cases. 
Chemotherapy is the only effective treatment for 
PCL (radiotherapy does not seem to improve patient 
survival rate, and a radical surgical approach is not re-
commended). R-CHOP is the primary chemotherapy 
regimen . The first cycle of chemotherapy must be given 
with caution due to a high risk of cardiac rupture dur-
ing rapid tumor regression.
15) 
In most patients, the RA is affected and infiltration 
within the conductive system can produce many types 
of arrhythmias: atrial fibrillation, AV block, sick sinus 
syndrome, ventricular tachycardia, and ventricular fi-
brillation. 
However, the treatment of arrhythmia itself is not a 
difference. Occasionally, as in this case, the arrhythmia 
itself is improved after lymphoma treatment. 
In this case, as shown on CT scan, lymphoma cells 
infiltrated into the AV node, leading to AV block. The 
patient’s ECG returned to normal sinus rhythm after 
R-CHOP chemotherapy, proving that infiltration af-
fected the conductive system. In the English literature, 
about 20 cases presenting with AV block have been de-
scribed. Among those cases, a pacemaker was inserted 
in patients with high degree AV block.
16-18) To the best 
of our knowledge, this case is the first to report on PCL 
with AV block in the Korean literature. 
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Fig. 7. Positron emission tomography CT revealing complete re-
mission state after 6 cycles of chemotherapy.  